Sep 6
|
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
|
Jul 11
|
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
|
Jul 6
|
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
|
Apr 26
|
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
|
Apr 25
|
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
|
Apr 24
|
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
|